Issued Patents All Time
Showing 1–19 of 19 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12253527 | Compositions and methods for treating age-related diabetes and related disorders | Sagar P. Bapat, Ye Zheng, Ronald M. Evans, Michael Downes, Ruth T. Yu | 2025-03-18 |
| 12213999 | Compositions and methods for treating type 1 and type 2 diabetes and related disorders | Ronald M. Evans, Eiji Yoshihara, Michael Downes, Ruth T. Yu | 2025-02-04 |
| 11981931 | Reprogramming progenitor compositions and methods of use thereof | Ronald M. Evans, Michael Downes, Yasuyuki Kida, Teruhisa Kawamura, Zong Wei +1 more | 2024-05-14 |
| 11760977 | Compositions and methods for organoid generation and disease modeling | Ronald M. Evans, Michael Downes, Eiji Yoshihara, Ruth T. Yu | 2023-09-19 |
| 11685901 | Compositions and methods for organoid generation and disease modeling | Ronald M. Evans, Michael Downes, Eiji Yoshihara, Ruth T. Yu | 2023-06-27 |
| 11542309 | Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose | Ronald M. Evans, Michael Downes, Sihao Liu, Ruth T. Yu | 2023-01-03 |
| 11440889 | Analogs of fexaramine and methods of making and using | Ronald M. Evans, Michael Downes, Sungsoon Fang, Jae Myoung Suh, Thomas J. Baiga +3 more | 2022-09-13 |
| 11428697 | Compositions and methods for treating age-related diabetes and related disorders | Sagar P. Bapat, Ye Zheng, Ronald M. Evans, Michael Downes, Ruth T. Yu | 2022-08-30 |
| 11376264 | Use of bromodomain-containing protein 9 antagonists in combination with vitamin D receptor agonists in diabetes treatment | Ronald M. Evans, Michael Downes, Zong Wei, Ruth T. Yu | 2022-07-05 |
| 10920199 | Reprogramming progenitor compositions and methods of use therefore | Ronald M. Evans, Michael Downes, Yasuyuki Kida, Teruhisa Kawamura, Zong Wei +1 more | 2021-02-16 |
| 10912800 | Compositions and methods for treating type 1 and type 2 diabetes and related disorders | Ronald M. Evans, Eiji Yoshihara, Michael Downes, Ruth T. Yu | 2021-02-09 |
| 10815203 | Analogs of fexaramine and methods of making and using | Ronald M. Evans, Michael Downes, Sungsoon Fang, Jae Myoung Suh, Thomas J. Baiga +3 more | 2020-10-27 |
| 10695404 | Treatment of steroid-induced hyperglycemia with fibroblast growth factor (FGF) 1 analogs | Ronald M. Evans, Michael Downes, Ruth T. Yu | 2020-06-30 |
| 10539572 | Compositions and methods for treating age-related diabetes and related disorders | Sagar P. Bapat, Ye Zheng, Ronald M. Evans, Michael Downes, Ruth T. Yu | 2020-01-21 |
| 10450277 | Analogs of fexaramine and methods of making and using | Ronald M. Evans, Michael Downes, Sungsoon Fang, Jae Myoung Suh, Thomas J. Baiga +3 more | 2019-10-22 |
| 10301268 | Analogs of fexaramine and methods of making and using | Ronald M. Evans, Michael Downes, Sungsoon Fang, Jae Myoung Suh, Thomas J. Baiga +3 more | 2019-05-28 |
| 9925243 | Chimeric fibroblast growth factor (FGF) 2/FGF1 peptides and methods of use | Jae Myoung Suh, Michael Downes, Ronald M. Evans, Senyon Choe, Witek Kwiatkowski | 2018-03-27 |
| 9925241 | Mutated fibroblast growth factor (FGF) 1 and methods of use | Jae Myoung Suh, Michael Downes, Ronald M. Evans, Ruth T. Yu | 2018-03-27 |
| 9546379 | Compositions and methods for treating type 1 and type 2 diabetes and related disorders | Ronald M. Evans, Eiji Yoshihara, Michael Downes, Ruth T. Yu | 2017-01-17 |